Allogeneic peripheral blood stem cell transplantation (APBSCT) for high-risk hematologic malignancies: The efficacy of tacrolimus (TCL) for the prevention of acute graft-versus-host disease (AGVHD).

被引：0
|
作者：
Uberti, JP [1 ]
Adams, PT [1 ]
Silver, SM [1 ]
Jacobson, PM [1 ]
Scalzo, A [1 ]
Hammelef, K [1 ]
Ayash, L [1 ]
Ratanatharathorn, V [1 ]
机构：
[1] UNIV MICHIGAN,MED CTR,DIV HEMATOL ONCOL,ANN ARBOR,MI
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4514 / 4514
页数：1
相关论文
共 50 条
  • [1] Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
    Pawarode, Attaphol
    Goldstein, Steven
    Couriel, Daniel R.
    Braun, Thomas
    Magenau, John M.
    Riwes, Mary Mansour
    Parkin, Brian
    Radojcic, Vedran
    Frame, David
    Choi, Sung
    Connelly, James
    Levine, John E.
    Yanik, Gregory A.
    Reddy, Pavan
    BLOOD, 2015, 126 (23)
  • [2] High risk of chronic graft-versus-host disease in unmanipulated allogeneic peripheral blood stem cell transplantation
    Kalayoglu-Besisik, S
    Budak-Alpdogan, T
    Yenerel, MN
    Sargin, D
    Tangün, Y
    BLOOD, 1998, 92 (08) : 2973 - 2975
  • [3] Association of whole blood tacrolimus (TCL) levels with acute graft-versus-host disease (AGVHD) and nephrotoxicity in allogeneic marrow or blood stem cell transplant recipients.
    Jacobson, PA
    Ratanatharathorn, V
    Ma, M
    Scalzo, A
    Wagner, L
    Schork, MA
    Silver, SM
    Adams, PT
    Uberti, JP
    BLOOD, 1997, 90 (10) : 4410 - 4410
  • [4] Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?
    Koc, H
    Gurman, G
    Arslan, O
    Ozcan, M
    Akan, H
    Ilhan, O
    Konuk, N
    Beksac, M
    Uysal, A
    BLOOD, 1996, 88 (06) : 2362 - 2364
  • [5] Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies
    JP Uberti
    SM Silver
    PT Adams
    P Jacobson
    A Scalzo
    V Ratanatharathorn
    Bone Marrow Transplantation, 1997, 19 : 1233 - 1238
  • [6] Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies
    Uberti, JP
    Silver, SM
    Adams, PT
    Jacobson, P
    Scalzo, A
    Ratanatharathorn, V
    BONE MARROW TRANSPLANTATION, 1997, 19 (12) : 1233 - 1238
  • [7] Allogeneic peripheral blood stem cell transplantation is not associated with a high risk of chronic graft-versus-host disease (cGVHD).
    Pavletic, S
    Tarantolo, S
    Oria, N
    Morris, M
    Lynch, J
    Ketcham, M
    Bierman, P
    Vose, J
    Reed, E
    Kessinger, A
    Armitage, J
    Bishop, M
    BLOOD, 1998, 92 (10) : 456A - 456A
  • [8] Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease
    Storek, J
    Gooley, T
    Siadak, M
    Bensinger, WI
    Maloney, DG
    Chauncey, TR
    Flowers, M
    Sullivan, KM
    Witherspoon, RP
    Rowley, SD
    Hansen, JA
    Storb, R
    Appelbaum, FR
    BLOOD, 1997, 90 (12) : 4705 - 4709
  • [9] Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Smith, TL
    Folloder, J
    Khouri, I
    Ueno, NT
    Mehra, R
    Körbling, M
    Huh, YO
    Giralt, S
    Gajewski, J
    Donato, M
    Cleary, K
    Claxton, D
    Braunschweig, I
    van Besien, K
    Andersson, BS
    Anderlini, P
    Champlin, R
    BLOOD, 1999, 94 (04) : 1465 - 1470
  • [10] Ocular Manifestation of Acute Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
    Takashi Saito
    Katsuji Shinagawa
    Katsuto Takenaka
    Keitaro Matsuo
    Tadashi Yoshino
    Katsuyuki Kiura
    Kenji Niiya
    Mine Harada
    International Journal of Hematology, 2002, 75 : 332 - 334
12345